Clinical Trial Update: Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating photodynamic therapy with silicon phthalocyanine 4 for actinic keratosis, Bowen's disease, non-melanoma skin cancer, or early-stage myc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis
• Bowen Disease
• Mycosis Fungoides
• Non-melanoma Skin Cancer

Drugs mentioned

• Silicon phthalocyanine 4 (silicon phthalocyanine 4)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Lymphoma, Non-melanomatous Skin Cancer | Phase 1 | Status: COMPLETED